Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce

BACKGROUND: Although it has been shown that allergen immunotherapy (AIT) is well‐tolerated in children, systematic and prospective surveillance of AIT safety in real life settings is needed. METHODS: The multinational Allergen Immunotherapy Adverse Events Registry (ADER) was designed to address AIT...

Descripción completa

Detalles Bibliográficos
Autores principales: Asllani, Julijana, Mitsias, Dimitrios, Konstantinou, George, Mesonjesi, Eris, Xhixha, Fatmira, Shehu, Esmeralda, Christoff, George, Noleva, Katia, Makris, Michael, Aggelidis, Xenofon, Turkalj, Mirjana, Damir, Erceg, Agache, Ioana, Tomic‐Spiric, Vesna, Stosovic, Rajica, Misirligil, Zeynep, Kosnik, Mitja, Popov, Todor A., Calderon, Moises, Papadopoulos, Nikolaos G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236500/
https://www.ncbi.nlm.nih.gov/pubmed/37357552
http://dx.doi.org/10.1002/clt2.12250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236500/
https://www.ncbi.nlm.nih.gov/pubmed/37357552
http://dx.doi.org/10.1002/clt2.12250

Ejemplares similares